MedPath

BROMELAIN-PAPAIN

BROMELAIN-PAPAIN

Discontinued
DIN Number

00565504

Drug Class

Human

Market Date

Dec 31, 1981

Company
HC

seroyal international inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00565504
AIG Number0715413001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A09AC02 MULTIENZYMES AND ACID PREPARATIONS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification56:16.00
Health Canada Classification

ACTIVE INGREDIENTS (7)

AMYLASEActive
Strength: 25 MG
Monograph: AMYLASE
AMYLOPSINActive
Strength: 50 MG
Monograph: AMYLOPSIN
BETAINE HYDROCHLORIDEActive
Strength: 200 MG
Monograph: BETAINE HYDROCHLORIDE
BROMELAINActive
Strength: 80 MG
Monograph: BROMELAIN
GLUTAMIC ACID HYDROCHLORIDEActive
Strength: 100 MG
Monograph: GLUTAMIC ACID HYDROCHLORIDE
LIPASEActive
Strength: 50 MG
Monograph: LIPASE
PAPAINActive
Strength: 125 MG
Monograph: PAPAIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.